Status:
TERMINATED
Treatment of Early Nasal Polyposis With Topical Triamcinolone
Lead Sponsor:
Steward St. Elizabeth's Medical Center of Boston, Inc.
Conditions:
Nasal Polyps
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatm...
Detailed Description
nasopore, a bio-absorbable nasal dressing, may offer an alternative route of sustained steroid drug delivery. The use of topical targeted intranasal steroids may prevent the routine adverse effects of...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients with early nasal polyposis
Exclusion
- Age \< 18 years
- Patients with active sinus infections
- Patients on long term steroids
- Allergy or sensitivity to steroids
- Patients with Antrochoanal polyps
- Patients who received topical steroids by bio-resorbable sponge or oral steroids
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01222871
Start Date
July 1 2010
End Date
August 1 2012
Last Update
June 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Elizabeth's Medical Center, 736 Cambridge St
Brighton, Massachusetts, United States, 02135